FMS - Fresenius recalls Sanxin hemodialysis syringes over leakage issues
2023-11-16 14:36:19 ET
More on Fresenius Medical Care
- Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2023 Earnings Call Transcript
- Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off
- Fresenius Medical Care Non-GAAP EPS of €0.57, revenue of €4.94B; raises FY23 outlook
- Fresenius sees GLP-1 drugs having neutral impact on its business: report
- Seeking Alpha’s Quant Rating on Fresenius Medical Care
For further details see:
Fresenius recalls Sanxin hemodialysis syringes over leakage issues